1. Apoptosis
  2. Apoptosis
  3. Nemorosone

Nemorosone 是 Clusia rosea 树脂的主要成分。Nemorosone 对癌细胞有抗增殖作用。Nemorosone 诱导 HT-29 和 LoVo 细胞凋亡 (apoptosis)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Nemorosone Chemical Structure

Nemorosone Chemical Structure

CAS No. : 351416-47-2

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥927
In-stock
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Nemorosone is the main component of the floral resin of Clusia rosea. Nemorosone has an antiproliferative effect on cancer cells. Nemorosone induces apoptosis in HT-29 and LoVo cells[1][2].

IC50 & Target

apoptosis[1]

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A2780 IC50
6.23 μg/mL
Compound: Nemorosone
Cytotoxicity against cisplatin-resistant human A2780 cells after 24 hrs
Cytotoxicity against cisplatin-resistant human A2780 cells after 24 hrs
[PMID: 18951805]
A2780 IC50
6.75 μg/mL
Compound: Nemorosone
Cytotoxicity against doxorubicin-resistant human A2780 cells after 24 hrs
Cytotoxicity against doxorubicin-resistant human A2780 cells after 24 hrs
[PMID: 18951805]
A2780 IC50
9.2 μg/mL
Compound: Nemorosone
Cytotoxicity against human A2780 cells after 24 hrs
Cytotoxicity against human A2780 cells after 24 hrs
[PMID: 18951805]
HCT-8 IC50
4.07 μg/mL
Compound: Nemorosone
Cytotoxicity against SN38-resistant human HCT8 cells after 24 hrs
Cytotoxicity against SN38-resistant human HCT8 cells after 24 hrs
[PMID: 18951805]
HCT-8 IC50
4.23 μg/mL
Compound: Nemorosone
Cytotoxicity against human HCT8 cells after 24 hrs
Cytotoxicity against human HCT8 cells after 24 hrs
[PMID: 18951805]
HCT-8 IC50
4.44 μg/mL
Compound: Nemorosone
Cytotoxicity against raltitrexed-resistant human HCT8 cells after 24 hrs
Cytotoxicity against raltitrexed-resistant human HCT8 cells after 24 hrs
[PMID: 18951805]
HEK293 IC50
4.2 μg/mL
Compound: Nemorosone
Cytotoxicity against HEK293 cells after 24 hrs
Cytotoxicity against HEK293 cells after 24 hrs
[PMID: 18951805]
HeLa IC50
2.9 μM
Compound: 3, Natural NEM
Cytotoxicity against human HeLa cells after 72 hrs by resazurin assay
Cytotoxicity against human HeLa cells after 72 hrs by resazurin assay
[PMID: 22944119]
HeLa IC50
3.3 μM
Compound: nemorosone
Cytotoxicity against human HeLa cells after 24 to 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 24 to 48 hrs by MTT assay
[PMID: 19497755]
HT-29 IC50
3.5 μg/mL
Compound: Nemorosone
Cytotoxicity against SN38-resistant human HT-29 cells after 24 hrs
Cytotoxicity against SN38-resistant human HT-29 cells after 24 hrs
[PMID: 18951805]
HT-29 IC50
5.18 μg/mL
Compound: Nemorosone
Cytotoxicity against 5-FU-resistant human HT-29 cells after 24 hrs
Cytotoxicity against 5-FU-resistant human HT-29 cells after 24 hrs
[PMID: 18951805]
HT-29 IC50
5.25 μg/mL
Compound: Nemorosone
Cytotoxicity against human HT-29 cells after 24 hrs
Cytotoxicity against human HT-29 cells after 24 hrs
[PMID: 18951805]
Jurkat IC50
4.6 μg/mL
Compound: Nemorosone
Cytotoxicity against human Jurkat cells after 24 hrs
Cytotoxicity against human Jurkat cells after 24 hrs
[PMID: 18951805]
K562 IC50
4.2 μg/mL
Compound: Nemorosone
Cytotoxicity against human K562 cells after 24 hrs
Cytotoxicity against human K562 cells after 24 hrs
[PMID: 18951805]
LNCaP IC50
1.81 μg/mL
Compound: Nemorosone
Cytotoxicity against etoposide-resistant human LNCAP cells after 24 hrs
Cytotoxicity against etoposide-resistant human LNCAP cells after 24 hrs
[PMID: 18951805]
LNCaP IC50
2.12 μg/mL
Compound: Nemorosone
Cytotoxicity against human LNCAP cells after 24 hrs
Cytotoxicity against human LNCAP cells after 24 hrs
[PMID: 18951805]
MCF7 IC50
3.3 μg/mL
Compound: Nemorosone
Cytotoxicity against 5-FU-resistant human MCF7 cells after 24 hrs
Cytotoxicity against 5-FU-resistant human MCF7 cells after 24 hrs
[PMID: 18951805]
MCF7 IC50
4.28 μg/mL
Compound: Nemorosone
Cytotoxicity against doxorubicin-resistant human MCF7 cells after 24 hrs
Cytotoxicity against doxorubicin-resistant human MCF7 cells after 24 hrs
[PMID: 18951805]
MCF7 IC50
4.37 μg/mL
Compound: Nemorosone
Cytotoxicity against human MCF7 cells after 24 hrs
Cytotoxicity against human MCF7 cells after 24 hrs
[PMID: 18951805]
MCF7 IC50
5.2 μM
Compound: 3, Natural NEM
Cytotoxicity against human MCF7 cells after 72 hrs by resazurin assay
Cytotoxicity against human MCF7 cells after 72 hrs by resazurin assay
[PMID: 22944119]
MIA PaCa-2 IC50
2.4 μM
Compound: 3, Natural NEM
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by resazurin assay
Cytotoxicity against human MIAPaCa2 cells after 72 hrs by resazurin assay
[PMID: 22944119]
NCI-H460 IC50
4.21 μg/mL
Compound: Nemorosone
Cytotoxicity against human H460 cells after 24 hrs
Cytotoxicity against human H460 cells after 24 hrs
[PMID: 18951805]
NIH3T3 IC50
> 50 μg/mL
Compound: Nemorosone
Cytotoxicity against Swiss mouse 3T3 cells after 24 hrs
Cytotoxicity against Swiss mouse 3T3 cells after 24 hrs
[PMID: 18951805]
PC-3 IC50
2.01 μg/mL
Compound: Nemorosone
Cytotoxicity against human PC3 cells after 24 hrs
Cytotoxicity against human PC3 cells after 24 hrs
[PMID: 18951805]
体外研究
(In Vitro)

Nemorosone (0-50 μM; 24-72 h) inhibits the proliferation of HT-29 and LoVo cells with IC50s of 25.7-27.1 μM, 22.8-64.3 μM, respectively[1].
Nemorosone (25.7 μM for HT-29; 22.8 μM for LoVo; 24, 48 hours) increases the percentage of G0/G1 phase cells[1].
Nemorosone (25.7 μM for HT-29; 22.8 μM for LoVo; 24, 48 hours) induces apoptosis in both cell lines[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: HT-29 and LoVo cells
Concentration: 0-50 μM
Incubation Time: 24-72 h
Result: Inhibited the proliferation of HT-29 and LoVo cells with IC50s of 25.7-27.1 μM, 22.8-64.3 μM, respectively.

Cell Cycle Analysis[1]

Cell Line: HT-29 and LoVo cells
Concentration: 25.7 μM for HT-29; 22.8 μM for LoVo
Incubation Time: 24, 48 hours
Result: Increased the percentage of G0/G1 phase cells.

Apoptosis Analysis[1]

Cell Line: HT-29 and LoVo cells
Concentration: 25.7 μM for HT-29; 22.8 μM for LoVo
Incubation Time: 24, 48 hours
Result: Induced apoptosis in both cell lines.
体内研究
(In Vivo)

Nemorosone (50 mg/kg; daily i.p. for 28 days) shows a significant growth-inhibitory effect in pancreatic cancer xenografts[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Athymic NMRI nu/nu nude mices (6 to 8 week old female), which had 100 mm3 MIA-PaCa-2 xenograft tumor[2]
Dosage: 50 mg/kg
Administration: Daily i.p. injections for 28 days
Result: Showed a significant growth-inhibitory effect in pancreatic cancer xenografts[2].
分子量

502.68

Formula

C33H42O4

CAS 号
性状

固体

颜色

White to off-white

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

纯度 & 产品资料

纯度: ≥99.0%

参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Nemorosone
目录号:
HY-121458
需求量: